These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11436263)

  • 1. The treatment of motor neurone disease.
    Turner M
    Practitioner; 2001 Jun; 245(1623):530-2, 536-8. PubMed ID: 11436263
    [No Abstract]   [Full Text] [Related]  

  • 2. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Kiernan MC
    Med J Aust; 2005 Apr; 182(7):319-20. PubMed ID: 15804220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of riluzole: who are the patients enrolled in the studies?
    Logroscino G; Zoccolella S
    Amyotroph Lateral Scler; 2007 Apr; 8(2):124-5; author reply 125. PubMed ID: 17453643
    [No Abstract]   [Full Text] [Related]  

  • 4. Motor neurone disease - caring for the patient in general practice.
    Zoing M; Kiernan M
    Aust Fam Physician; 2011 Dec; 40(12):962-6. PubMed ID: 22146323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC; Burke D; Pamphlett R; Kiernan MC
    J Clin Neurosci; 2006 Jan; 13(1):78-83. PubMed ID: 16410201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preface: the state of the science of all motor neuron diseases.
    Weiss MD; Carter GT
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):xix-xx. PubMed ID: 18625405
    [No Abstract]   [Full Text] [Related]  

  • 7. Riluzole for motor neurone disease. More trials are needed.
    Sandercock J; Burls A; Hyde C; Fry-Smith A; Barton P; Bryan S; Stewart A
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403060
    [No Abstract]   [Full Text] [Related]  

  • 8. Riluzole for motor neurone disease. Large, more economical trial is needed.
    Wheatley K; Gray R
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403061
    [No Abstract]   [Full Text] [Related]  

  • 9. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Henderson RD; McCombe PA
    Med J Aust; 2005 Aug; 183(3):164; author reply 164-5. PubMed ID: 16053424
    [No Abstract]   [Full Text] [Related]  

  • 10. ALS, motor neuron disease, and related disorders: a personal approach to diagnosis and management.
    Pascuzzi RM
    Semin Neurol; 2002 Mar; 22(1):75-87. PubMed ID: 12170396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole for motor neurone disease. Reply from chairman of appraisal committee at NICE.
    Barnett D
    BMJ; 2001 Sep; 323(7312):573. PubMed ID: 11573490
    [No Abstract]   [Full Text] [Related]  

  • 12. A retrospective review of specialist palliative care involvement in motor neurone disease.
    Ryan R; Tracey G; Lawlor P; O'Siorain L; Higgins S
    Ir Med J; 2012; 105(10):335-8. PubMed ID: 23495545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of motor neurone disease.
    Leigh PN; Abrahams S; Al-Chalabi A; Ampong MA; Goldstein LH; Johnson J; Lyall R; Moxham J; Mustfa N; Rio A; Shaw C; Willey E;
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74 Suppl 4(Suppl 4):iv32-iv47. PubMed ID: 14645465
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
    Stewart A; Sandercock J; Bryan S; Hyde C; Barton PM; Fry-Smith A; Burls A
    Health Technol Assess; 2001; 5(2):1-97. PubMed ID: 11809124
    [No Abstract]   [Full Text] [Related]  

  • 15. Motor neuron disease associated with multiple myeloma.
    Koc F; Paydas S; Yerdelen D; Demirkiran M
    Int J Neurosci; 2008 Mar; 118(3):337-41. PubMed ID: 18300006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
    Mitchell JD; O'brien MR; Joshi M
    Amyotroph Lateral Scler; 2006 Jun; 7(2):67-71. PubMed ID: 16753969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Easier access to motor neurone drug.
    Smith W
    Nurs N Z; 2004 Oct; 10(9):5. PubMed ID: 19777649
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and management of motor neurone disease.
    McDermott CJ; Shaw PJ
    BMJ; 2008 Mar; 336(7645):658-62. PubMed ID: 18356234
    [No Abstract]   [Full Text] [Related]  

  • 19. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to palliative care for people with motor neurone disease in New Zealand: a patient's perspective.
    Williams B
    N Z Med J; 2005 Oct; 118(1224):U1711. PubMed ID: 16258583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.